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Abstract
Plasmodium vivax infects a hundred million people annually and endangers 40% of the world’s population. Unlike
Plasmodium falciparum, P. vivax parasites can persist as a dormant stage in the liver, known as the hypnozoite, and these
dormant forms can cause malaria relapses months or years after the initial mosquito bite. Here we analyze whole genome
sequencing data from parasites in the blood of a patient who experienced consecutive P. vivax relapses over 33 months in a
non-endemic country. By analyzing patterns of identity, read coverage, and the presence or absence of minor alleles in the
initial polyclonal and subsequent monoclonal infections, we show that the parasites in the three infections are likely meiotic
siblings. We infer that these siblings are descended from a single tetrad-like form that developed in the infecting mosquito
midgut shortly after fertilization. In this natural cross we find the recombination rate for P. vivax to be 10 kb per
centimorgan and we further observe areas of disequilibrium surrounding major drug resistance genes. Our data provide
new strategies for studying multiclonal infections, which are common in all types of infectious diseases, and for
distinguishing P. vivax relapses from reinfections in malaria endemic regions. This work provides a theoretical foundation for
studies that aim to determine if new or existing drugs can provide a radical cure of P. vivax malaria.
Citation: Bright AT, Manary MJ, Tewhey R, Arango EM, Wang T, et al. (2014) A High Resolution Case Study of a Patient with Recurrent Plasmodium vivax Infections
Shows That Relapses Were Caused by Meiotic Siblings. PLoS Negl Trop Dis 8(6): e2882. doi:10.1371/journal.pntd.0002882
Editor: Mauricio Martins Rodrigues, Federal University of Sa˜o Paulo, Brazil
Received December 2, 2013; Accepted April 7, 2014; Published June 5, 2014
Copyright:  2014 Bright et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: EAW was supported by National Institutes of Health Grants R21-AI085374-01A1, 5R01AI090141-03 and 1R01AI03058-01A1. ATB was supported in part
by the UCSD Genetics Training Program through an institutional training grant from the National Institute of General Medical Sciences (T32 GM008666). RT and
NJS were supported by NIH/NCRR Grant Number UL1 RR025774. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Stephanie.Yanow@albertahealthservices.ca (SKY, for clinical questions); ewinzeler@ucsd.edu (EAW, for sequencing questions)
Introduction
Plasmodium vivax is the most widespread of the human malaria
parasite species with 2.85 billion people living in areas at risk for P.
vivax infection [1]. Worldwide there are approximately 100 million
cases of P. vivax annually, and the severity of P. vivax infection is
increasingly recognized as more cases of death and drug resistance
are reported [2]. The predominant biological mechanism that
accounts for the increased range of P. vivax is the ability of these
parasites to persist as dormant liver stages known as hypnozoites.
This unique parasite stage is metabolically inactive and can
remain dormant for months to years before reemerging to cause
clinical disease [3,4]. Asymptomatic hypnozoite carriers therefore
represent a major impediment to malaria elimination efforts.
Despite the large burden of P. vivax malaria throughout the
world, little is definitively known about hypnozoite reactivation.
Recent reports in the literature have shown that relapses occurring
in patients with a low number of hypnozoites in their liver are
usually clonal and the relapse parasites are genetically homologous
to the parasites from the initial infection [5–7]. In contrast most
relapse infections in endemic settings, where patients harbor
hypnozoites from multiple infectious mosquito bites, are polyclonal
infections caused by parasites genetically heterologous to the initial
infection [8–10]. The heterologous infections do share some alleles
suggesting the parasites share a common ancestor [8] but the
polyclonal nature and higher allelic diversity [11] of these
infections along with the limited number of genetic markers used
in previous studies make it difficult to assess the specific genetic
relationship.
The complex dynamics of P. vivax relapse infections prevents
using genotyping methods to classify recurrent malaria episodes in
the field as relapse infections caused by hypnozoites, as recrudes-
cent infections caused by a failure to clear the initial infection, or
as reinfections. The inability to distinguish between the three
causes of recurrent malaria infection in endemic areas prevents
accurate estimates of hypnozoite prevalence and inhibits the
ability to study this parasite stage directly. Furthermore, the
inability to distinguish relapse infections from reinfections prevents
drug efficacy trials in endemic countries, impeding the develop-
ment of the next generation of anti-hypnozoite drugs and
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hindering a thorough understanding of resistance to primaquine,
the only currently licensed drug able to clear hypnozoites and
achieve a radical cure.
Due to these confounding aspects of relapse infection, studies of
travelers who move into an endemic region, contract malaria
once, and then leave could be particularly informative. Here we
report the analysis of whole genome sequencing data from
sequential recurrent parasite infections obtained from a patient
who had a P. vivax malaria episode shortly after arriving in Canada
from Sudan (where the infection occurred), and subsequently
experienced two relapses, 3 months and 33 months after the first
episode, despite treatment with the recommended drug regimen.
Analysis of single nucleotide variants (SNVs) identified in the three
recurrent malaria infections demonstrate that while the first
recurrent infection was polyclonal, the two subsequent infections,
which can be definitively categorized as relapse infections, were
clonal. In addition, comparison of the SNVs identified in the three
infections demonstrate that the parasites isolated from the patient
are most likely meiotic siblings and are the result of a single sexual
cross in the mosquito vector.
Materials and Methods
Ethics statement
The protocol used to collect human blood samples for this work
was approved by the Health Research Ethics Board of the
University of Alberta and written informed consent was obtained
from the patient. The consent form states in English that blood
samples collected from the patient may be used to genetically
characterize the parasites and that samples may be shared with
other researchers for scientific purposes.
Sample collection
P. vivax DNA used in this study was isolated from a symptomatic
patient who was blood smear positive for P. vivax malaria in
Alberta, Canada as previously described [12]. The patient was a
38-year-old male originally from Eritrea. In December 2008 he
spent nearly one month in Sudan where, according to patient
history, he contracted malaria for the first time in his life. The
patient was treated with chloroquine but not primaquine. After
treatment, he relocated to Canada in mid-January 2009 and
experienced his first recurrent episode (EAC01) within two weeks
of arrival. He was treated with chloroquine (600 mg base
immediately, 300 mg base at 6, 24, and 48 h) and primaquine
(30 mg daily P.O. for 14 d) as standard clinical care. The patient
recovered clinically and was blood smear negative for malaria on
day 16. Subsequently, the patient experienced two relapse episodes
within 3 months (EAC02) and 33 months (EAC03) of his initial
recurrent infection in Canada. During EAC02, the patient was
treated with the same regimen of chloroquine as before but was
given an extended 28 d dose of primaquine (30 mg P.O. daily) and
was blood smear negative after two days. During the final episode
of this study, the patient was treated with chloroquine for three
days and received standard primaquine (14 d 30 mg P.O. daily)
and was again blood smear negative after two days and recovered
clinically. At each episode, EDTA-preserved blood was collected
from the patient and submitted to the Provincial Laboratory for
Public Health (Edmonton, Canada) for routine confirmation of
malaria by real-time PCR. Blood from the first two episodes was
stored at 220uC prior to use for sequencing. Whole blood from
the third episode was centrifuged to pellet red blood cells and
stored at 280uC.
Genotyping of eight genetic makers
Parasite DNA was extracted from 40 mL of whole blood using
the PSS GC12 instrument (Precision System Science Co. Ltd.)
with the DNA 200 protocol and kits (E2003). DNA was eluted into
a 100 mL volume. Genotyping was based on sequence repeats in
the microsatellites 1.501, 3.502, 3.27, and MS16, as well as the
genes msp1F3, msp3a, msp4 and msp5 using the primers and
protocol as previously described [13]. All molecular markers were
amplified by nested or semi-nested PCR using 3 mL of extracted
DNA as a template in the first amplification step and 1 mL of the
first PCR product for the second amplification. The PCR reaction
was performed in a final volume of 20 mL containing 1X PCR
buffer (Qiagen), 2 mM of MgCl2 (Qiagen), 200 mM of each dNTP
(Takara Bio), 0.25 mM of each primer, and 1.5 units of HotStar
Taq DNA polymerase (Qiagen). The cycling program was as
follows: 5 min at 95uC followed by 30 cycles of denaturation for
1 min at 95uC, annealing for 1 min at 56uC–62uC (depending on
the marker analyzed), and elongation for 1 min at 72uC with a
final elongation for 5 min at 72uC.
PCR was performed in a Thermal Cycler 2720 (Applied
Biosystems). Amplification was confirmed in a 2% agarose gel and
PCR products were stored at 4uC in the dark. The product size
was resolved by capillary electrophoresis in an ABI Prism 3100
Genetic Analyzer (Perkin Elmer Applied Biosystems), using GS500
LIZ as the internal size standard and the microsatellite settings.
The results were analyzed using GeneMapper software (version
3.5; Applied Biosystems). All electropherograms were inspected
visually and peaks above a cut off of 300 relative fluorescent units
(RFU) were considered true amplification products. Based on the
repeat length, alleles were grouped into 3-bp bins for MS16,
msp1F3, msp3a, msp4 and msp5, 4-bp bins for 3.27, 7-bp bins for
1.501 or 8-bp bins for 3.502. Multiple alleles per locus were scored
if minor peaks were .33% of the height of the predominant allele
present for each locus.
Isolation and quantification of genomic DNA for whole
genome sequencing
For samples EAC01, EAC02, and EAC03, bulk genomic DNA
was isolated from frozen whole blood samples using the DNeasy
Blood and Tissue kit (Qiagen) as per the manufacturers
instructions.
A Taqman qPCR assay for P. vivax b-tubulin (PVX_094635)
was used to assess the P. vivax DNA quantity in the bulk gDNA
Author Summary
Plasmodium vivax is capable of remaining dormant in the
human liver for months to years after an initial infection,
creating an asymptomatic human reservoir. This unique
aspect of parasite biology makes eliminating P. vivax
distinctly different from P. falciparum elimination, and yet
very little is known about this dormant parasite stage. Lack
of knowledge about the dormant liver stage prevents the
creation of new drugs and public health interventions
directed at P. vivax. In order to better understand this
particular parasite stage, we used whole genome sequenc-
ing to analyze three sequential P. vivax infections, two of
which could be definitively categorized as having arisen
from dormant liver stages. Our whole genome sequencing
data demonstrates that dormant liver stage parasites are
closely related yet not, as had previously been postulated,
identical. These data highlight the need for a new
paradigm to investigate P. vivax dormant liver stages in
order to design the next generation of P. vivax drugs and
effective global health interventions.
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isolated from the patient blood sample (Primer 1: CGAAAG-
GAAGCAGAAGGATG and Primer 2: GGGGAGGGGAA-
TACTGAAAA with a Hydrolysis Probe of CAGGTAGTGG-
TATGGGAACCTTGCTGA). The qPCR reaction was
conducted using Applied Biosystems Taqman 26 Genotyping
Master Mix (Life Technologies), 20 ng bulk genomic DNA,
900 nM of each primer, and 250 nm of the fluorescent hydrolysis
probe. Reactions were carried out on an Applied Biosystems
StepOne Plus (Life Technologies) using the manufacturers
standard protocol. A 12-point standard curve was made from
Sal1 reference DNA originally obtained from the CDC by serially
diluting 20 ng of Sal1 gDNA 1:2 for a theoretical lower limit of
quantitation of 0.02% P.vivax DNA. Total P vivax DNA was
calculated by comparing the Ct value of the sample to the 12-point
standard curve of Sal1 reference DNA.
Whole genome capture
Whole genome capture (WGC) of the initial infection and the
relapse samples was performed as previously described [14].
Briefly, Illumina TruSeq v. 3-style Y-adaptors (CCACTCATG-
CAGGTGAGCGTC*T and /Phos/GACGCTCACC-
TATGTCTCCCT) were ligated onto Sal1 reference genomic
DNA that had been sheared to 200 bp using an S-series Covaris
Adaptive Focused Acoustic machine (Covaris). The T7 promoter
sequence (bold) was added into the standard Illumina amplifica-
tion primers (TTC[TAATACGACTCACTATAGGG]AGACA-
TAGGTGAGCCTC and CCACTCATGCAGGT-
GAGCGTCT) used to amplify the ligated products. To create
the whole genome baits, the resulting library was used in an in
vitro transcription reaction following the manufacturers protocol
(Ambion MEGAshortscript T7 Kit, Life Technologies) with the
exception that biotin labeled dUTP was used in replacement of the
supplied dUTP.
Bulk genomic DNA was carried through the standard Illumina
whole genome sequencing (WGS) library preparation process
using Adaptive Focused Acoustics for shearing (Covaris), end-
repair, A-tailing and ligation (New England Biolabs). Hybridiza-
tion capture was carried out as previously described [14,15].
Briefly, 750 ng of the whole genome baits were incubated with
500 ng of the bulk genomic DNA-fragment library along with
2.5 mg of human Cot-1 DNA, 2.5 mg of salmon sperm DNA,
2.5 ug of Human genomic DNA, and 1 unit of blocking
oligonucleotides complementary to the Illumina TruSeq v. 3
adaptor and incubated for 24 hours at 65uC. After the hybridiza-
tion, the captured targets were selected by pulling down the
biotinylated probe/target hybrids by using streptavidin-coated
magnetic beads (Dynabeads MyOne Streptavidin T1; Life
Technologies) as previously described [14].
Whole genome sequencing and data analysis
Whole genome capture samples were sequenced on an Illumina
Hi-Seq2000 at the TSRI Next Generation Sequencing Core
Facility. Samples were paired-end sequenced for 101 bp per read
and one 7 bp index read using Illumina v. 3 chemistry. Base calls
were made using Illumina RTA (v. 1.12) software. Data for each
sample sequenced in this study is available in the NCBI Sequence
Read Archive [SRA057904].
Fastq files obtained from sequencing were aligned to the Sal1
reference using BWA (v. 0.5.9) with soft clipping of bases with
quality score 2 and below [16]. PCR duplicates were next
identified and marked using Picard (v. 1.51) MarkDuplicates.
Aligned reads were then realigned around indels and areas of high
entropy using GATK (v. 1.3+) IndelRealigner, and the base
quality scores of realigned reads were then recalibrated using
GATK TableRecalibration [17,18]. After realignment and
recalibration the samples were considered ‘‘clean’’ and ready for
use in downstream analysis.
Genome wide coverage and loci covered to a certain percentage
were calculated using GATK DepthOfCoverage [18]. For all
GATK DepthOfCoverage analyses the minimum mapping quality
(mmq) was set to 29 and the minimum base quality (mbq) was set
to 20.
SNV discovery was conducted on the ten publicly available P.
vivax genomes [North Korea I: SRP000316, Mauritania I:
SRP000493, Brazil I: SRP007883, India VII: SRP007923,
IQ07: SRP003406, SA94–SA98: SRA047163]. Only those reads
from each sample that aligned in proper pairs were used in the
SNV discovery process (samtools view –f 2) [19]. SNVs were
identified in each sample individually using GATK UnifiedGen-
otyper and stringent filters were applied to achieve the highest
confidence SNV set possible with GATK VariantFiltration. The
filters used included minimum depth of coverage of 20, minimum
ReadDepthAndAllelicFractionBySample of 1.0, maximum Fish-
er’s Exact test for strand bias of 3.0, and maximum Haplotype-
Score of 3.0. Additionally SNVs were required to be biallelic with
respect to Sal I and SNVs that were within 50 bp of each other
were both excluded. The resulting 10 high stringency genotype
sets were combined into a single set of 55,399 high confidence
SNVs.
The 55,399 high confidence SNVs identified in the SNV
discovery process outlined above were then genotyped in all three
samples using GATK UnifiedGenotyper. Those loci with multi-
allelic genotypes were used only for analysis of clonality. The
resulting VCF file was annotated using SnpEff v. 3.3 (snpeff.sour-
ceforge.net) [20] and principal components analysis and all SNV
plots were completed with MATLAB v. 7.12.0.635 (The Math-
works).
For the Fws calculation the reference and alternate read depths
were extracted from the VCF file and used in Equation 1 where pw
and ps are the allelic frequency of the reference allele within the
sample and within the population, respectively, and qw and qs are
the allelic frequency of the alternate allele within the sample and
within the population, respectively [21].
Fws~1{(Hw=Hs)
Hw~1{(pw
2zqw
2)
Hs~1{(ps
2zqs
2)
ð1Þ
Regions of contiguous DNA that were identical between
samples were identified and a weighted average block size metric
(HapBlockMet) was calculated for each pairwise comparison using
all identified haplotype blocks according to Equation 2 where d is
the length of the block.
HapBlockMet~
P
d2
P
d
ð2Þ
Copy number variants were detected using a novel CNV
detection algorithm [22]. Briefly, after reads were aligned to the
reference genome, depth of coverage was normalized for GC bias
across the entire genome excluding the apicoplast and mitochon-
dria. Regions were considered amplified if the average of
continuous bases normalized by a Gaussian curve with standard
deviation of 50 bases showed a two fold or greater read coverage
P. vivax Relapses Caused by Meiotic Siblings
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relative to the rest of the genome. Genome fold coverages were
analyzed in a per region fashion, with each region that had a
statistically significantly higher coverage (p,0.05, normalized for
number of regions, two-proportion z-test compared to average)
being called as a copy number variant. The size of the region was
varied, with the first and last base pair positions being considered
the boundaries of the CNV, and the region that produced the most
significant result was considered to have the true CNV boundaries.
Results
Analysis of sequential recurrent P. vivax infections
The patient, a 38-year-old male from Northeast Africa, moved
to Canada in mid-January 2009 and presented with P. vivax
malaria one month after experiencing his first primary infection in
Sudan. During this initial recurrent infection, the patient was
treated with the recommended regimen of both chloroquine and
primaquine. After subsequent recovery, the patient presented with
P. vivax malaria again three months later and was treated with
chloroquine and an extended 28-day course of primaquine. Thirty
months later the patient presented with a third recurrent P. vivax
malaria infection and was given a standard dose of chloroquine
and primaquine. Throughout the three malaria infections the
patient had not travelled outside of areas in North America known
to be non-endemic for malaria, thereby ruling out reinfection [12].
According to the patient’s medical history, the first recurrent
infection (EAC01) was classified as either a recrudescence caused
by a failure to clear parasites from the primary infection in Sudan
or a relapse infection caused by reactivation of a dormant
hypnozoite. The second (EAC02) and third (EAC03) recurrent
infections were classified as relapse infections since parasites were
cleared from the patient after each preceding infection in Canada.
Infected blood samples were collected during each malaria episode
and frozen. Because of the unique history of this patient, the
samples were thawed and examined after the third malaria
episode.
Whole genome sequencing
Although the P. vivax-infected patient blood samples had not
been collected using the leukocyte depletion protocol required for
efficient direct sequencing analysis of P. vivax samples [23,24], we
were able to sequence the three parasite strains using a whole
genome capture technique utilizing RNA baits derived from the
SalI reference strain of P. vivax [14] using an in-solution
hybridization capture procedure [15,25]. Briefly, in this method
the P. vivax DNA from a patient sample hybridizes to the
biotinylated RNA baits and the DNA/RNA hybrids are then
purified using streptavidin beads, resulting in the depletion of most
of the contaminating human DNA. This method enriched the P.
vivax DNA, which initially comprised less than 1.0% of the total
genomic DNA (gDNA) in the patient infected whole blood
samples, to 20%–40% of total DNA content allowing efficient
whole genome sequencing analysis of the parasite DNA (Table 1).
Enriched P. vivax gDNA was sequenced on an Illumina HiSeq
2000 using 100 base-pair paired end reads and 5.1–8.5 billion
bases were obtained for each parasite strain resulting in genome
wide coverage of 35X–118X (Table 1). In addition, for all three
samples, .88% of the genome could be assigned a confident
genotype (Table 1).
Several types of reads were evident in comparison to the SalI
reference sequence. These include clear homozygous single
nucleotide variants such as the one causing the S117N change
in the P. vivax dihydrofolate reductase gene (PVX_089950) (Figure 1A),
biallelic reads (Figure 1B), such as the ‘‘T’’ in the isoleucine codon
and the ‘‘C’’ in the valine codon at amino acid 1478 in the P. vivax
multidrug resistance associated protein (PVX_097025), and multiallelic
reads in a noncoding region on chromosome 13 (Figure 1C).
Although the biallelic reads appeared real and, in many cases,
involve alleles present in other P. vivax isolates, multiallelic reads,
such as that shown in Figure 1C, appeared to be due to alignment
errors based on the fact that numerous mismatches are found
throughout the read. These alignment errors were subsequently
removed by excluding cases where there were more than 1 SNV in
50 bases. These misalignments were not used in further analyses.
The single and biallelic reads, their readcount, and their position
in the genome are given in Supporting Dataset 1.
Genotyping of single nucleotide variants
In order to examine the origins of the parasites, we first sought
to identify the genetic differences between the three infections by
examining their genome sequence. Using the whole genome
sequencing data, we genotyped the three P. vivax infections at
55,399 positions (Table 2). These loci were selected by analyzing
the genome sequences of 10 diverse P. vivax strains from the NCBI
Sequence Read Archive and identifying the location of SNVs that
differed from the SalI reference sequence. SNVs included in this
set of markers were required in at least one of the 10 sequences to
have a minimum coverage of 20 reads and all reads indicating the
presence of a single allele. These markers were spaced, on average,
408 bases apart across the genome and the distribution was similar
across all chromosomes (data not shown). Approximately 44% of
the SNVs genotyped were located in coding regions, which
constitute 54.6% of the genome (Table 2).
The samples analyzed here were different from the SalI
reference genome at 23,379, 20,734, and 20,934 of the genotyped
loci for EAC01, EAC02, and EAC03, respectively (Table 2). Of
these variant loci, 19,667, 19,623, and 20,110 had five or more
reads mapping to the locus in EAC01, EAC02, and EAC03,
respectively, and were considered high quality genotype calls
(Table 2).
In order to establish that all the infections were of East African
origin, as suggested by the patient’s medical history, we compared
the three infections isolated here with five geographically diverse P.
vivax strains for which both sequencing data and geographical data
are publicly available using the same 55,399 loci [23,26]. Using
principal components analysis [27], we show that our three
parasite strains from East Africa are very closely related to one
another (Figure 2). In addition, the three samples from our patient
are most closely related to the West African Mauritania I and
India VII strains and are diverged from P. vivax samples from
South America and the North Korea I strain (Figure 2). Principal
components analysis corroborates the patient’s medical history
and offers further proof that he was not reinfected by an unrelated
P. vivax strain while residing in Canada.
Analysis of SNVs: Clonality
With the dense set of genetic markers obtained from WGS data
we next sought to establish the clonality of the three infections. For
this analysis we used both single and biallelic genotype calls in
EAC01, -02, and -03, and calculated the percentage of loci
containing more than one allele in this haploid organism as an
indicator of clonality. The parasites in the first blood sample
(EAC01) were determined to be polyclonal with 43.7% (8,603 of
the 19,667 variant loci with 5 or more reads) possessing more than
one allele (Table 2). In addition, the Fws value, another indicator of
multi-clonal infections which compares the parasite diversity
within a single patient to the parasite diversity seen on the
P. vivax Relapses Caused by Meiotic Siblings
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population level [21,28], is 0.51 (clonal = 1.0) for the initial
infection and is suggestive of more than one clone (Table 2) [28].
In contrast, both relapses arising from hypnozoites activated 30
months apart (EAC02 and EAC03) appeared to be clonal based
upon the same metrics as above (Table 2), which is consistent with
previous reports of relapse infections in non-endemic settings
[6,29]. The first relapse (EAC02) had an Fws of 0.97 and the
second relapse had an Fws of 0.94 (Table 2). In addition both
relapse samples had very few loci with multiple alleles (258 (1.31%
of total SNVs) for EAC02, 303 (1.51% of total SNVs) for EAC03)
at the variant genotyped loci (Table 2). For EAC03, 69% (45) of
the 303 multi-allelic loci also gave mixed reads in one of the other
sequenced samples (e.g. India VII, IQ07, Brazil 1, North Korea or
Mauritania) suggesting these loci are in an area of the P. vivax
genome which is problematic to sequence using current short-read
technology. In addition, more than 35% of these multi-allelic loci
in EAC02 and EAC03 were clustered in subtelomeric regions and
regions encoding internal variable gene families, which comprise
only 12% of the P. vivax genome (Table 2). Also of note, the
distribution of multi-allelic loci was nonrandom with many of the
mixed read alleles mapping to one 70 kb fragment on the right
arm of chromosome 7, suggesting that this region might be
duplicated in the three East African isolates. We therefore
conclude that these few loci containing multiple alleles in the
clonal samples are most likely the result of sequencing/alignment
errors to these highly variable sequences, which frequently
duplicate and recombine during mitotic growth [30].
To compare these findings using conventional methods, the
three P. vivax infections were subjected to eight-marker RFLP
genotyping, which represents the current standard in character-
izing P. vivax diversity. The markers used here consisted of four
microsatellites and four genes of the highly variable merozoite surface
protein family, all of which have been shown to be variable in
previous studies [13,31,32]. These regions were amplified using
PCR (see methods), and the size of the PCR products were
analyzed on an ABI Prism 3100 Genetic Analyzer. As expected,
Table 1. Sequencing statistics for whole-genome capture samples.
Isolate Sequenced bases (billion) P. vivax gDNA (%) PCR duplicates (%) Coverage (X) Genome Callablea (%)
EAC01 5.1 19.57% 14.20% 34.81 88.2%
EAC02 6.0 36.48% 12.41% 75.96 94.0%
EAC03 8.5 39.67% 11.89% 118.22 96.0%
aBase pair covered by 5 or more reads.
doi:10.1371/journal.pntd.0002882.t001
Figure 1. Representative genotype calls. Examples of read alignments from (A) a homozygous SNV (S117N) in P. vivax dihydrofolate reductase
(PVX_089950), (B) a heterozygous SNV in the P. vivax multidrug resistance protein 1 (PVX_097025) and (C) a rare multiallelic SNV on chromosome 13
that is suggestive of an alignment error based on multiple mismatches (indicated by arrows) in the fragments carrying the G at the central position.
All reads are from EAC01. The Sal I reference allele is shown below.
doi:10.1371/journal.pntd.0002882.g001
P. vivax Relapses Caused by Meiotic Siblings
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Table 2. SNV genotyping set: East African sample SNV statistics.
EAC01 EAC02 EAC03
Genotyped loci 55,399 55,399 55,399
Total SNVs 23,379 20,734 20,934
SNVs covered .5 reads 19,667 19,623 20,110
Homozygous SNVs 11,064 19,365 19,807
Heterozygous SNVs 8,603 258 303
% Heterozygous 43.74% 1.31% 1.51%
Fws 0.51 0.97 0.94
% Heterozygous SNVs in variable regions 15.65% 35.37% 41.45%
% Genome consisting of variable regions 11.97% 11.97% 11.97%
# SNVs in coding regionsa 10,401 9,102 9,147
# Synonymous SNVsa 4,248 3,674 3,682
# Non-synonymous SNVsa 6,153 5,428 5,465
Base pairs per SNVa 967 1,091 1,080
% SNVs in coding regionsa 44.5% 43.9% 43.7%
% of genome consisting of coding regionsb 54.6% 54.6% 54.6%
aOnly homozygous SNVs are used in the calculation.
bGenome size - 22,621,101 bp; Coding regions - 12,348,368 bp.
doi:10.1371/journal.pntd.0002882.t002
Figure 2. Principal components analysis. The East African samples sequenced in this study cluster by themselves as compared to the publicly
available P. vivax samples that possess geographic information [North Korea I: SRP000316, Mauritania I: SRP000493, Brazil I: SRP007883, India VII:
SRP007923, IQ07: SRP003406]. They are most closely related to IndiaVII and Mauritania I (West Africa). They are highly diverged from North Korea I
and the South American strains. Principal components analysis was performed using MATLAB.
doi:10.1371/journal.pntd.0002882.g002
P. vivax Relapses Caused by Meiotic Siblings
PLOS Neglected Tropical Diseases | www.plosntds.org 6 June 2014 | Volume 8 | Issue 6 | e2882
the first infection (EAC01) showed multiple bands for 6 of the 8
markers, while EAC02 and EAC03 appeared monoclonal, with
only a single band for each of the 8 markers for EAC02, and 7 of
the 8 markers for EAC03, where three bands were observed for
the 3.27 microsatellite marker (Table 3). It seems unlikely that this
extra band is informative given that the regions appear perfectly
identical in EAC02 and EAC03 in this region by whole genome
sequencing (Figure 3). It is possible that the extra bands for the
3.27 marker are due to either contamination or PCR artifacts
resulting from mis-hybridization of the PCR primers for this
marker in the East African isolates. These data suggest that
microsatellite genotyping of field isolates, although standard, may
lead to inaccurate conclusions about polyclonal infections.
Analysis of SNVs: Determination of genetic relatedness
We next sought to determine the genetic relatedness between
the recurrent parasite infections using the genotyped markers.
Genotyping at the 55,399 loci showed that 4,434 (32.8%) of the
13,536 genotyped positions (5 or more reads) that were variant
between the three infections produced different base calls in the
two relapse samples (Supporting Dataset 1), contradicting the
microsatellite analysis showing that the two relapses are virtually
identical (Table 3). This result initially suggested that these two
episodes might have come from different infection events. To
investigate further, EAC02 and EAC03 were subsequently
subjected to a pairwise comparison in which confidently
genotyped markers were plotted as a function of chromosome
position (Figure 3). Surprisingly, these data indicate that the
parasites exhibited a highly non-random pattern in which regions
of identity were organized into large blocks with a weighted
average size of 715 kb and that the microsatellite markers were
located by chance in regions that happened to lack variant SNVs.
As a control, the two relapse samples were also compared in a
pairwise manner to the Brazil I strain since this strain is also
believed to be derived from a relapse infection. We observed no
evidence that the relapse samples shared large contiguous
sequences of DNA with this South American strain (Figure 3).
We additionally calculated the haplotype block sizes from pairwise
comparisons between EAC02 and Brazil I and EAC02 and
Mauritania 1 (the strain most closely related by PCA to the East
African samples investigated here). The haplotype block sizes for
these comparisons were 5.8 kb and 6.3 kb, respectively, indicating
that EAC02 shared no large contiguous pieces of DNA with these
other P. vivax stains.
We next compared the two definitive relapse samples to the first
sample (EAC01) at those loci that were unambiguously genotyped
in all three infections. We again found that the strains obtained
from our patient over 33 months shared substantial portions of the
P. vivax genome and that the regions of identity were organized
into contiguous blocks of genomic sequence (data not shown and
Supporting Dataset 1). These analyses further suggest that
parasites from all three infections are highly related, yet genetically
distinct, to one another.
Since EAC01 was a polyclonal infection, we sought to
determine if it was comprised exclusively of parasites directly
related to EAC02 and EAC03. If EAC01 only contained parasites
that were directly related to the second and third infections, then
genotyped loci in EAC01 would not contain more than two alleles.
Of the 10,775 loci that contained more than one allele in EAC01
only six loci (5.661024%) possessed more than two alleles with
high confidence (greater than 5 reads). These data suggest that the
first infection is comprised of two or more parasites directly related
to EAC02 and EAC03. Additionally, when EAC01 variant mixed-
read alleles from chromosome one were sorted by read count
(Table 4) one resulting haplotype perfectly matched that of EAC02
and EAC03 (which are identical on chromosome 1) and the other
was completely different. These data suggest that either there are
three clones, one with the chromosome 1 EAC02/03 haplotype
and two with the alternative haplotype, or that there are only two
different clones present, but that EAC02/03 haplotype clone is less
abundant (Table 3).
Overall these data suggest that EAC02 and EAC03 and the two
clones in EAC01 are separated by only a single meiosis. In the
related human parasite, P. falciparum, sexual crosses performed
using chimpanzees showed that the average number of bases per
100 recombination events (one centimorgan= 10 kb) is 9.6 kb
[33]. Based on the 27 breakpoints shown in Figure 3 over the
26.9 Mb P. vivax genome [34] we estimate that the average
number of bases per 100 recombinations is a similar 10 kb.
Although no laboratory crosses of P. vivax have been performed,
our clones appear to be the progeny of a natural cross.
Reciprocal recombination events
The malaria parasite undergoes sexual reproduction during the
mosquito life cycle stage including recombination between male
and female gametes. Since the infections were most likely caused
by ‘‘sibling’’ parasites, we next sought to determine if they had
arisen from a single zygote and if there was evidence of reciprocal
recombination events, which would indicate a direct genetic
relationship between the parasite strains from the recurrent
infections. To accomplish this task we analyzed the whole genome
sequencing data in multiple two way comparisons that separated
Table 3. Genomic location and band size of eight genetic markers in P. vivax [37].
Primer Location (bp)
Genetic Marker Chrom. Forward Reverse EAC01 EAC02 EAC03
Microsatellite 1.501 1 473,732 473,905 107 107 107
Microsatellite 3.502 3 451,079 451,266 142, 174 174 174
Microsatellite 3.27 3 493,033 493,402 271, 299 271 271, 259
msp4 4 627,608 628,049 197, 221 197 197
msp5 4 630,303 630,795 330, 360 360 360
msp1F3 7 1,161,359 1,161,802 259, 253 250 250
Microsatellite MS16 9 1,593,168 1,593,791 220,100 256 256
msp3a 10 1,220,104 1,220,928 465 474 474
doi:10.1371/journal.pntd.0002882.t003
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the two clones in EAC01 into two different virtual clones
(EAC01A and EAC01B) based on read count (Figure 4). While
it is recognized that this is not ideal because stochastic differences
in read count are highly likely, without the parental haplotype a
third sample is, nevertheless, necessary to visualize reciprocal
events. This is because although a recombination event can be
found that occurred in one sibling but not the other using WGS,
reciprocal events would be invisible. Because of the potential for
noise we further filtered the set to include only the highest quality
base calls. Specifically, we used a dataset of 5938 positions that had
at least 20 reads across EAC01, EAC02, and EAC03 major alleles.
Regions were plotted across the chromosome and colored based
on whether they were identical or different. Comparisons between
EAC01A and EAC01B, EAC02, and EAC03 and a fourth
comparison between EAC02 and EAC03 are shown in Figure 4.
The two clones (EAC02 and EAC03) and the two virtual clones
(EAC01A and EAC01B) were identical across much of the
genome. As suggested previously, on chromosome 1, EAC01B,
EAC02 and EAC03 were almost identical (different at 1 of 94 loci
genotyped), but different from EAC01A at 93 of these loci. It is not
clear that the microsatellite genotyping (Microsatellite 1.501,
Table 3) would have detected the EAC01A virtual clone, but
conventional microsatellite genotyping of chromosome 1 showed
only 1 product in all three isolates for marker 1.501. Likewise,
there was no evidence of recombination on chromosome 5 (183 of
183 loci identical in EAC01B, EAC02, and EAC03). Nevertheless,
clear evidence of reciprocal recombination events were visible on
all other chromosomes with most chromosomes having between 1
and 4. These breakpoints were identified as areas of the genome
where one clone transitions from sharing a haplotype to not
sharing a haplotype (Figure 4). It should be noted that breakpoints
detected using read counts of the two virtual clones (EAC01A and
EAC01B) were confirmed with the two independently sequenced
samples, EAC02 and EAC03. An example of one of these events
on chromosome 9 at base pair resolution is shown in Figure 4. The
high-resolution data show that the recombination event occurred
between bases 1,872,017 and 1,879,466. The four clones analyzed
here share 21 recombination breakpoints, which is in concordance
with the number of crossovers postulated to occur per meiosis in P.
falciparum [33,35].
Regions of homozygosity and drug resistance
As noted above, the patient here was treated with primaquine
after both the first and second infection, yet still suffered additional
relapse infections, suggesting that the parasites could be resistant to
primaquine. Although the number of samples here is too small to
map a resistance gene we nevertheless looked to see if known drug
resistance genes were heterozygous or homozygous across the
different infections and thus could indicate evidence of positive
selection.
The P. vivax pfcrt homolog (PVX_087980) on chromosome 1 was
identical across all three infections with only two synonymous
mutations (D328 and F339) in comparison to the SalI reference
strain within a region of homozygosity that spanned 11,912 bases.
Figure 3. Pairwise comparison of EAC02 and EAC03. A set of 23,755 SNVs confidently genotyped (20 or more reads) in EAC02, EAC03 and
Brazil I and which are different from SalI are presented across 14 chromosomes. SNVs shared between the two strains are shown in lavender and
positions where the two strains differ are shown in dark purple, revealing large regions of identity. The positions of the eight-microsatellite markers
(Table 3) are indicated by arrows, including the region on chromosome 4 where the msp4 and msp5 markers are in a region of homozygosity
surrounded by regions of heterozygosity (inset). Despite the two samples being identical at the eight microsatellite markers, they differ at many
positions in the genome. A comparison between EAC02 and a Brazil I control strain (in red and blue) shows that the two strains are highly diverged
and do not share blocks of contiguous DNA sequence.
doi:10.1371/journal.pntd.0002882.g003
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For the multidrug resistance loci pvmdr (PVX_080100), pvmrp
(PVX_097025), and gtp cyclohydrolase (PVX_123830) we found
there were two haplotypes present across the three infections.
But for pvdhfr (PVX_089950) and pvdhps (PVX_123230), genes
involved in anti-folate resistance, there was only one haplotype
across all three infections, revealing an area known to be
under selection in that region of the world [36]. For pvdhfr the
region of homozygosity on chromosome 5 was 23 kb, but for
pvdhps on chromosome 14, the region of homozygosity spanned
132 kb.
Along with SNVs in putative resistance genes, we also looked
for copy number variants (CNV), a key mechanism of resistance
in P. falciparum [37–40], in P. vivax homologs of known P.
falciparum drug resistance genes (Table 5). In the three infections
analyzed here, we were unable to detect any amplification CNVs
(.2.0 sequencing coverage relative to the genomic average) at the
genes of interest using a novel CNV detection algorithm [22]. In
addition, we did not detect any significant differences in relative
sequencing coverage between the three infections. However,
although the algorithm used here (see Methods) has been shown
to robustly identify CNVs in P. falciparum, in the absence of
genome-captured P. vivax DNA samples with known CNVs
that could serve as positive controls, false negatives could be
possible.
Discussion
Here we show whole genome sequencing results for three
sequential recurrent P. vivax infections, two of which could be
definitively categorized as relapse infections, occurring in a patient
over 33 months in a non-endemic country. These results
demonstrate the feasibility of using the whole genome capture
technique on archived samples after long term storage along
with standard samples directly from the field to dramatically
improve our understanding of P. vivax infections within a single
patient.
These data also demonstrate the power available from the more
comprehensive datasets produced with whole genome technologies
to more accurately describe the genetic structure both within a
geographic region and also temporally within a single patient.
Comparing the whole genome sequencing data to the current
standard of RFLP on 8–15 markers demonstrates that data from
small genotyping sets are more susceptible to common errors. For
instance EAC03 had three bands by RFLP analysis at the
microsatellite 3.27, but analysis of this region by whole genome
sequencing using hundreds of markers showed this region to be
clonal. The most likely cause for this error is a PCR error, and
while whole genome sequencing is not immune to PCR errors the
high level of read counts at each individual locus along with the
Figure 4. Multiple two-way comparisons show evidence of reciprocal recombination events. To ensure that only high quality positions
would be used, the 55,399 genotyped loci were stringently filtered. The filtering criteria was that there had to be more than 20 read counts for the
major allele of each comparison (EAC01, EAC02, and EAC03), and that all three strains’ SNV positions differed from the reference. A likelihood function
was generated examining 10,000 basepair windows for recombination and assumed that each transition (same to different in each pairwise
comparison taken individually) could be considered a chance of recombination. A smoothing kernel was applied to differentiate if a position was
likely to be the same by chance or due to recombination and depended on the distance of identical neighboring SNVs (the further separated
identical SNVs were, the chances of a true recombination event was much less). Only edges with Z scores greater than 4.188 (99th percentile) were
taken as true edges. For the inset, the numbers below the line represent read count. On the right side of the recombination event, there is no minor
allele in EAC01 and thus EAC01A and EAC01B are presumed to be identical, while on the left side, the minor allele (EAC01B) read count is relatively
high. RC= Read Count. Dark arrows indicate reciprocal recombination events found in three or more comparisons.
doi:10.1371/journal.pntd.0002882.g004
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dense set of markers across the entire genome make the technique
more robust than the current standard genotyping methods.
Additionally, as the cost of sequencing declines, new methods
like whole genome capture will make it feasible to generate larger
more complete genetic datasets of malaria infections. These new
datasets will allow more robust characterization of recurrent
infections; better classification of recurrent P. vivax infections will
be crucial in designing next generation anti-malarials as well as
public health interventions directed specifically at P. vivax.
The latter two of the three recurrent malaria infections analyzed
here can be definitively classified as relapse infections, which arose
from the activation of hypnozoites. Prior to each of these two
infections the patient had been negative for malaria infection by
diagnostic PCR, ruling out a recrudescence. Furthermore, the
patient history stated that the patient had not been to a malaria
endemic country since the previous malaria infection, ruling out a
reinfection.
Both of the definitive relapse samples (EAC02 and EAC03) were
clonal based on analysis of the whole genome sequencing data.
This suggests that a single hypnozoite was activated through an
unknown trigger and emerged from the liver to cause symptomatic
disease. In contrast the first recurrent infection, whose origin could
not be distinguished between a relapse and recrudescence, was
polyclonal. These results are in concordance with previous studies
looking at relapse samples from patients with limited or no
previous malaria infection [5,6]. Additionally, the clonality seen
in the final infection might be a result of the extended course of
primaquine the patient received after the second infection. This
treatment regimen might have selected only one highly resistant
hypnozoite leading to a clonal infection as an artifact of
treatment. Therefore clonality might be suggested as a marker
for relapse infection only in these specific circumstances. In
contrast, reports from the literature indicate that relapse
infections occurring in endemic areas can be either clonal or
polyclonal due to the hypnozoite load in the liver that has
accumulated from previous mosquito inoculations [8–10]. The
high degree of relatedness between the two infections also
corroborates the patient’s medical history indicating that the
parasites causing these two infections separated by 30 months
were acquired in the same region at the same time. If the patient
had travelled to another malaria endemic region, the parasites
causing infection would be genetically different, and, if the patient
had returned to East Africa, the recombination breakpoints
would have been different. These data also support the idea that
the parasites are from the same sub-geographic region within
East Africa and not a combination of parasites from Sudan and
Eritrea, for instance.
From a public health perspective, these data highlight the need
for analyzing P. vivax samples from the field with a denser genetic
array than has previously been performed. While EAC02 and
EAC03 are highly related as described above, there are still
substantial portions of the P. vivax genome where they differ.
Nevertheless, the traditional eight-marker genotyping panel
indicated that these two parasites were identical at all eight
markers suggesting that these two infections were clones of one
another, which is not corroborated by the denser genomic data.
Also, looking at the pairwise comparison between EAC02 and
EAC03 demonstrates that selecting a different set of eight random
markers from the genome could just as easily have indicated the
parasites where completely unrelated. We demonstrate here that
the current gold standard techniques investigating 8–15 genes or
microsatellites will be unable to fully describe the complex genetic
structure of P. vivax infections.
Further genomic analysis of the two definitive relapse samples
indicates that these two infections are highly related. These two
infections share large amounts of DNA, and the DNA that is
homologous between these two P. vivax strains is organized into
large contiguous blocks of genomic DNA, or haplotypes. The
average size of the haplotype blocks shared by these two parasite
strains (715 kb) is roughly half the size of the average chromosome
(1.5 Mb) indicating that these two samples are separated by a
single round of meiosis (Figure 5). Comparing the second and third
infection to the first infection also indicated that these parasite
strains arose from the same parental gametes. Additionally,
genomic analysis demonstrated that these three parasite samples
shared reciprocal recombination breakpoints. While it is not
uncommon to find distinct recombination breakpoints in malaria
samples collected from a specific region, especially one where
transmission is quite low [41,42], the fact that reciprocal
recombination breakpoints were found, and that all recombination
breakpoints identified were reciprocal, further illustrates the direct
genetic relatedness of these three infections.
Table 5. Copy number variants in putative drug resistance genes from relapsing clones.
Relative Gene Coverage
Gene Chromosome Start End EAC01 EAC02 EAC03
pvcrt 1 330,260 334,540 1.0419 1.0451 1.0438
PVX_087980
pvmrp 2 153,642 158,822 0.7052 0.7406 0.7355
PVX_097025
pvdhfr 5 964,590 966,469 0.6123 0.6134 0.6233
PVX_089950
pvmdr1 10 361,490 366,095 1.4668 1.4562 1.4432
PVX_080100
pvdhps 14 1,256,701 1,259,581 1.1466 1.1476 1.1538
PVX_123230
pvgtp-cyclohydrolase 14 1,824,997 1,826,268 0.7978 0.7781 0.7839
PVX_123830
doi:10.1371/journal.pntd.0002882.t005
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Figure 5. Genetic cycle of P. vivax relapse predicted from whole genome sequencing. The primary infection (EAC01) is polyclonal with at
least two, and possibly more, meiotic siblings. It is inferred that this infection came from the activation of two different hypnozoites (EAC01A and
EAC01B). Based on the higher number of reads from EAC01A, this hypnozoite may have been activated first. It is also possible that asexual parasites
descended from a third meiotic sibling are present in the EAC01 infection but its DNA was poorly amplified. The two relapses (EAC02 and EAC03) are
predicted to be clonal. This model is based on relapses coming from a single hypnozoite, which may be rare in regions where individuals are
repeatedly infected with P. vivax and where there may be many circulating haplotypes.
doi:10.1371/journal.pntd.0002882.g005
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In single-celled eukaryotes such as S. cerevisiae, a single zygote
can give rise to four meiotic progeny that constitute a ‘‘tetrad’’ and
show reciprocal recombination breakpoints. We hypothesize based
on the recombination data that the direct genetic relationship
hypothesized here is of meiotic siblings from the same zygote. This
meiotic sibling hypothesis would imply that sporozoites from a
single viable oocyst were injected into the patient at the time of the
infectious mosquito bite. Due to the low transmission rate in the
area of infection and the low oocyst burden of mosquitoes seen in
the field, this is the most likely scenario.
A potential alternative to the meiotic sibling hypothesis is that
the parasites seen here constitute a family trio. This parent-child
relationship could be seen one of two ways. One, the patient might
have been infected by three separate mosquitoes each carrying a
separate member (mother, father, and child) of the trio. Further
analysis of the epidemiology of P. vivax in East Africa and, in
particular in Sudan, indicates that a parent-child relationship
between multiple infections, while genetically feasible, is unlikely
due to low transmission rates in the area [41,42].
The second mechanism by which the patient could have been
infected by this nuclear family of parasites is for the patient to have
been infected by one mosquito harboring multiple oocysts. In the
parent-child relationship structure, sporozoites from at least three
oocysts would have had to be injected into the patient: one with
the cross, and two self-crosses for each of the parental strains. In
addition, there would have most likely been additional oocysts
present that contained additional crosses that would have also
been injected. Recombination data to date from the initial
polyclonal infection has not found evidence of additional parasite
crosses between two putative parental strains further suggesting
that the genetic relationship between these parasites are not a
parent-child relationship.
There is also the possibility that there was previously one cross
in the region of inoculation with the four descendants of this cross
circulating in the area and maintaining themselves by consecutive
self-crosses in the mosquito. Under this hypothesis, the patient in
this study would have been sequentially infected by three of these
strains. Based on the data and malaria transmission characteristics
in the Sudan, we believe this hypothesis is of low probability for
two reasons. One, the patient is unlikely to have received three
infectious bites during his short stay in Sudan, an area of low
malaria transmission. Two, if the sexual cross had occurred more
than one generation ago, it is unlikely that the parasites would
share all recombination breakpoints. For this to happen, the
parasites from the initial cross would have to have been segregated
via multiple human infections or multiple mosquitoes immediately
after the initial cross since otherwise the chance of all four progeny
only self-crossing in the next generation is unlikely. In this area of
low transmission it is unlikely that multiple mosquitoes would have
transmitted progeny from the initial cross to three or four other
individuals and it is equally unlikely that the same mosquito would
have infected three of four other people, each with a different
progeny from the same cross. For these two reasons, both relating
to the low transmission dynamics of the region of inoculation, the
possibility of the cross seen here occurring .1 generation ago is
small.
We of course cannot definitively distinguish between the
alternative hypothesis relationships without the putative fourth
member of the tetrad. Despite this fact, the meiotic sibling
hypothesis is the most likely of the proposed hypotheses at this time
as it best conforms to the P. vivax population structure and
transmission rate present in Sudan.
Additionally, the dense genetic maps obtained via whole
genome sequencing highlight a new, unique aspect of P. vivax
immune evasion. It is known from therapeutic malaria experiments
in the first half of the 20th century that patients can become immune
to successive relapse infections [3]. However, these infections were
initiated by only a few strains usually propagated by blood
transfusion which were likely genetically identical. Here we suggest
that in a natural infection resulting from the sexual cross of two
different parasites, up to four genetically unique parasites emerge
from each oocyst (Figure 5). These diverse parasites have a greater
chance to evade the human immune response as they are
subsequently activated and emerge from the liver. These high-
resolution data in which haplotypes can be distinguished simply
based on read count offer the opportunity to use linkage analysis of
complex patient samples in mapping drug resistance genes. Higher
levels of read coverage could also allow physical mapping and de novo
assembly of clones in a mixed infection.
Whole genome sequencing of sequential P. vivax infections
including definitive relapses also strengthens a classic model of P.
vivax biology with genomic data. Studies in the first half of the 20th
century of P. vivax relapse using malaria therapy for neurosyphilis
as a model demonstrated that both a short latency relapse and a
long latency relapse can arise from parasites that are directly
related to one another [43]. Confirming these initial results, we
show here on the genomic level that genetically related parasites
from the same cross can cause both a short and long latency
relapse infection. This further confirms that P. vivax parasites are
inherently capable of remaining dormant in the liver for months to
years unless activated by the appropriate (unknown) trigger. These
data also highlight the need to better understand the trigger that
activates hypnozoites, currently hypothesized to be a febrile illness
[44], and/or hypnozoite biomarkers that can be used for long-
term surveillance for P. vivax infections in tropical areas as part of
malaria elimination programs.
Another area of interest highlighted by this particular case is
primaquine resistance. The patient was treated with a standard dose
of primaquine after the initial infection and a double dose after the
first relapse, but the parasites were obviously able to evade this
treatment. At this point, it is unclear whether the failure of
primaquine was due to parasite resistance or the patient’s inability
to metabolize primaquine to its active form. If these genetically
related parasites are resistant to primaquine then it is possible that
the patient initially harbored a more diverse hypnozoite load in the
liver that was cleared after primaquine treatment. However,
analysis of the initial recurrent infection, obtained before prima-
quine treatment, does not suggest this to be the case, but it cannot be
definitively ruled out. This patient’s history nevertheless demon-
strates that primaquine is not always effective and that safe,
efficacious replacements are needed. A major obstacle to both
testing new anti-hypnozoite drugs and for monitoring the effective-
ness of primaquine in endemic countries is the inability to
distinguish between the sources of recurrent infection.
This study is limited by its inherent uniqueness. With only three
samples to date, we are unable to definitively answer many of the
outstanding questions, such as the exact genetic relationship between
strains and primaquine resistance. In addition, the answer to the
relationship structure between the three infections would be more
easily answered if the P. vivax community possessed a more solid
understanding of the population structure in Sudan, but due to the
political instability in the region this is currently not feasible. In order
to overcome these limitations, more relapse samples, and preferably
multiple sequential relapse samples from a single patient, need to be
obtained. These infections can be either naturally occurring or
controlled P. vivax infections based on new protocols [45].
Further in depth analysis of definitive relapse infections will shed
more light on this crucial parasite stage, but, as demonstrated in
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this study, current relapse analysis methods lack the power to fully
characterize the hypnozoite stage for either research or public
health purposes. The hypnozoite will therefore need to be the
focus of specific intervention programs if the goal of malaria
elimination is to be realized in areas endemic for P. vivax.
Supporting Information
Dataset S1 Genotyping data from the three samples sequenced
in this study (EAC01-03) and five publicly available P. vivax
samples for the genomic loci in the genotyping set (see Methods).
SNVs in genes are noted along with whether they are synonymous
or non-synonymous base pair changes.
(XLSX)
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